Niagen Bioscience (NAGE) Research & Development (2015 - 2026)
Niagen Bioscience (NAGE) reported Research & Development of $1.5 million for Q1 2026, up 17.73% year-over-year from $1.3 million in Q1 2025, and down 13.39% quarter-over-quarter from $1.7 million in Q4 2025.
Niagen Bioscience (NAGE) Research & Development (2015 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 12 years of Research & Development data on file, last reported at $1.5 million in Q1 2026.
- Research & Development for Q1 2026 came in at $1.5 million, up 17.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 million (up 26.53% YoY), and the FY2025 annual result was $6.3 million, up 5.22% from the prior year.
- Research & Development eased to $1.5 million in Q1 2026 per NAGE's latest filing, from $1.7 million in the prior quarter.
- Over five years, Research & Development peaked at $2.1 million in Q1 2024 and troughed at $1.1 million in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.3 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development jumped 75.61% in 2024, then plunged 39.95% in 2025.
- A 5-year view of Research & Development shows it stood at $1.3 million in 2022, then retreated by 9.38% to $1.2 million in 2023, then rose by 13.46% to $1.3 million in 2024, then jumped by 30.04% to $1.7 million in 2025, then retreated by 13.39% to $1.5 million in 2026.
- Business Quant data shows NAGE's Research & Development at $1.5 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 996,000.00 |
| Jun 30, 2021 | 1.00 Mn |